Kaggen Ausma
About Kaggen Ausma
Kaggen Ausma serves as the Head of Corporate Strategy and Chief of Staff at Generate:Biomedicines. He has a background in economics and law, with previous roles at McKinsey & Company and PYC Therapeutics.
Current Role at Generate Biomedicines
Kaggen Ausma serves as the Head of Corporate Strategy and Chief of Staff at Generate Biomedicines. He has been in this role since 2023, contributing to the strategic direction and operational management of the organization. His responsibilities include overseeing corporate strategy initiatives and ensuring alignment across various departments. Prior to this position, he held the role of Senior Director of Strategy at the same company for nine months.
Previous Experience at Generate Biomedicines
Before his current role, Kaggen Ausma worked at Generate Biomedicines as Director of Strategy from 2022 to 2023. In this capacity, he was involved in developing and implementing strategic initiatives that supported the company's growth objectives. His tenure at Generate Biomedicines has spanned multiple roles, reflecting his expertise in strategic planning within the biomedicine sector.
Experience at McKinsey & Company
Kaggen Ausma has extensive experience with McKinsey & Company, where he worked in various roles from 2015 to 2019. He began as a Business Analyst in Perth, Australia, for two years, followed by a promotion to Associate in 2018. He later served as an Engagement Manager for six months. His time at McKinsey provided him with a strong foundation in consulting and strategic analysis.
Educational Background
Kaggen Ausma completed his education at The University of Western Australia, where he earned a Bachelor of Laws and a Bachelor of Economics (Honours) from 2009 to 2015. Prior to that, he attended Albany Senior High School from 2002 to 2007. His academic background in law and economics has equipped him with a diverse skill set applicable to his roles in corporate strategy and business development.
Experience at PYC Therapeutics and CLSA
Kaggen Ausma served as Chief Business Officer at PYC Therapeutics from 2019 to 2022, where he focused on business development and strategic partnerships. Earlier in his career, he worked as an Economics Analyst at CLSA from 2008 to 2014, gaining insights into economic trends and market analysis. These roles have contributed to his expertise in corporate strategy and business operations.